欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3096/003
药品名称Cresnisol
活性成分
    • Alanine 16.0 g/l
    • Arginine 10.9 g/l
    • Aspartic acid 3.2 g/l
    • Glutamic acid 5.53 g/l
    • Glycine 7.68 g/l
    • Histidine 6.6 g/l
    • Isoleucine 5.53 g/l
    • Leucine 7.68 g/l
    • Lysine 8.64 g/l
    • Methionine 5.53 g/l
    • Phenylalanine 7.68 g/l
    • Proline 6.6 g/l
    • Serine 4.38 g/l
    • Threonine 5.53 g/l
    • Tryptophan 1.85 g/l
    • Tyrosine 0.28 g/l
    • Valine 7.08 g/l
剂型Solution for infusion
上市许可持有人Baxter A/S Tobaksvejen 2 A 2860 Søborg Denmark
参考成员国 - 产品名称Denmark (DK)
Cresnisol
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Germany (DE)
      Flosol 11,1 % Infusionslösung
许可日期2021/01/13
最近更新日期2024/12/12
药物ATC编码
    • B05BA01 amino acids
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase